NCT05992181

Brief Summary

The study concerns the creation and implementation of a digital tool presenting the various orofacial stimuli that can be offered to premature newborns. This app is intended for parents, to allow them to play a more active role in their child's care, and provide them with special time with their child. The notion of pleasure is very important to us, and it's vital to help parents rediscover this feeling with their child. Different profiles will be created to individualize our recommendations, facilitate the understanding of orofacial stimuli, make them more concrete than drawings, and provide care adapted to each patient and improve the development of newborns through more regular orofacial stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 15, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2024

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

July 28, 2023

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Milk taken daily

    Percentage of the amount of milk taken daily (measure taken once per week throughout the study).

    up to 3 months

Secondary Outcomes (6)

  • Behavior scale for the analysis of oral reflexes and suction reflexes (MIAM questionnaire)

    Day 0, Day 15, Day 30, Day 45, Day 60, Day 75, Day 90

  • Feeding behavior scale for premature infants moving to bottle-feeding (ECEPAB questionnaire

    Day 0, Day 15, Day 30, Day 45, Day 60, Day 75, Day 90

  • Milk flower (PIBBS questionnaire)

    Day 0, Day 15, Day 30, Day 45, Day 60, Day 75, Day 90

  • Newborn Pain and Discomfort Scale (EDIN questionnaire)

    Day 0, Day 15, Day 30, Day 45, Day 60, Day 75, Day 90

  • anxiety questionnaire

    Day 0, Day 30, Day 60, Day 90

  • +1 more secondary outcomes

Study Arms (2)

control group

NO INTERVENTION

With the speech therapy already in place in the department.

experimental group

EXPERIMENTAL

With the speech therapy already in place in the department, plus access to videos and the introduction of early orofacial stimulation.

Other: NEORTHO

Interventions

NEORTHOOTHER

early orofacial stimulation

experimental group

Eligibility Criteria

Age24 Hours - 3 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child born prematurely before 29 weeks of amenorrhea (SA).
  • Alive for minimum 24h.
  • Holders of parental authority who have been informed of the study and have not objected.

You may not qualify if:

  • Child born after 29 weeks of amenorrhea.
  • with a genetic or severe neurological pathology or withdrawal syndrome.
  • with a vital prognosis.
  • whose family home is too far from the service.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, 91106, France

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 15, 2023

Study Start

September 15, 2023

Primary Completion

June 20, 2024

Study Completion

June 20, 2024

Last Updated

August 15, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations